Note to Authors

Please note that new standards for page and color publication fees are in effect starting with Volume 2, Issue 2 of mAbs. For additional information and a guide to estimate charges please click here.

In this issue

mAbs
Volume 2, Issue 2
March/April 2010
View current issue
About the cover
The cover image depicts an antibody engineered for enhanced complement- and cell-mediated effector functions. Designed modifications in the Fc region that...
Continue reading


About the Journal

mAbs accepted for inclusion for Medline  11.6.09

In January of 2009 mAbs, the first international peer-reviewed journal of its kind to focus exclusively on monoclonal antibodies, was launched. We believe that this is an excellent time to start the journal because of the increasing focus on mAbs as therapeutics. There has been a rapid increase in mAb R&D by academia, government and industry located world wide. Novel mAb therapeutics are entering clinical study by commercial sponsors at a record pace (Figure 1) that is predicted to continue well into the future. MAbs have proven successful in the clinic (Table 1). In addition, a global market has emerged for the products - several novel mAbs not yet available in the US or EU are now approved in China.


HINARI

Landes Bioscience gladly participates in the World Health Organizations' Access to Research Initiative (HINARI) to provide free online access to all papers published in mAbs to scientists in developing countries worldwide.

Read more about the HINARI initiative.

Editor-in-Chief

Janice M. Reichert, Ph.D.

Email the Managing Editor.

Print ISSN: 1942-0862
Online ISSN: 1942-0870 DOI: 10.4161/mabs

Meetings of interest

Keystone Symposia: New Paradigms in Cancer Therapeutics
March 23–28, 2010, Victoria, British Columbia, Canada

Comparability for Biologics
April 12–13, 2010, London, UK

BioTrinity 2010
April 12–14, 2010, Newbury, UK

15th International Human Antibodies &
Hybridomas Conference

April 14–16, 2010, Porto, Portugal

 

Links of Interest


Advertisements